AR019724A2 - Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas - Google Patents

Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas

Info

Publication number
AR019724A2
AR019724A2 ARP990103110A ARP990103110A AR019724A2 AR 019724 A2 AR019724 A2 AR 019724A2 AR P990103110 A ARP990103110 A AR P990103110A AR P990103110 A ARP990103110 A AR P990103110A AR 019724 A2 AR019724 A2 AR 019724A2
Authority
AR
Argentina
Prior art keywords
treatment
pharmaceutical composition
composition useful
associated conditions
mellitus diabetes
Prior art date
Application number
ARP990103110A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR019724A2 publication Critical patent/AR019724A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Una composicion farmacéutica que comprende un sensibilizador a insulina, un secretagogo de insulina, un agente antihiperglucémico inhibidor dealfa-glucosidasa, y un vehículo farmacéuticamente aceptable, util para el tratamiento de la diabetes mellitus y las condiciones asociadas con la diabetesmellitus en un mamífero.
ARP990103110A 1997-07-18 1999-06-28 Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas AR019724A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
AR019724A2 true AR019724A2 (es) 2002-03-13

Family

ID=10816170

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980103482A AR016350A1 (es) 1997-07-18 1998-07-16 Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos
ARP990103110A AR019724A2 (es) 1997-07-18 1999-06-28 Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980103482A AR016350A1 (es) 1997-07-18 1998-07-16 Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos

Country Status (27)

Country Link
EP (1) EP1001784A1 (es)
JP (1) JP2001510160A (es)
KR (1) KR20010021952A (es)
CN (1) CN1263467A (es)
AP (1) AP2000001735A0 (es)
AR (2) AR016350A1 (es)
AU (1) AU8449098A (es)
BG (1) BG104062A (es)
BR (1) BR9810292A (es)
CA (1) CA2297133A1 (es)
CO (1) CO4940489A1 (es)
DZ (1) DZ2563A1 (es)
EA (1) EA200000140A1 (es)
GB (1) GB9715298D0 (es)
HU (1) HUP0003626A3 (es)
ID (1) ID23804A (es)
IL (1) IL133907A0 (es)
MA (1) MA24608A1 (es)
NO (1) NO20000230L (es)
OA (1) OA11312A (es)
PE (1) PE99499A1 (es)
PL (1) PL338140A1 (es)
SK (1) SK612000A3 (es)
TR (1) TR200000133T2 (es)
UY (1) UY25101A1 (es)
WO (1) WO1999003478A1 (es)
ZA (1) ZA986364B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6660716B1 (en) * 1999-06-21 2003-12-09 Eli Lilly And Company Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof
DK1248604T4 (da) * 2000-01-21 2012-05-21 Novartis Ag Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler
US20030040490A1 (en) * 2000-02-24 2003-02-27 Yasuo Sugiyama Drugs containing combined active ingredients
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
CA2725833A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
GEP20084570B (en) 2003-10-31 2008-12-25 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219136T2 (de) * 1991-08-26 1997-08-28 Pharmacia & Upjohn Co., Kalamazoo, Mich. Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
UY25101A1 (es) 2000-12-29
SK612000A3 (en) 2000-07-11
CA2297133A1 (en) 1999-01-28
KR20010021952A (ko) 2001-03-15
BG104062A (en) 2000-11-30
DZ2563A1 (fr) 2003-02-15
AP2000001735A0 (en) 2000-01-16
HUP0003626A3 (en) 2001-12-28
GB9715298D0 (en) 1997-09-24
HUP0003626A2 (hu) 2001-05-28
WO1999003478A1 (en) 1999-01-28
AU8449098A (en) 1999-02-10
PE99499A1 (es) 1999-12-18
PL338140A1 (en) 2000-09-25
NO20000230D0 (no) 2000-01-17
ID23804A (id) 2000-05-11
EA200000140A1 (ru) 2000-06-26
IL133907A0 (en) 2001-04-30
AR016350A1 (es) 2001-07-04
CN1263467A (zh) 2000-08-16
JP2001510160A (ja) 2001-07-31
MA24608A1 (fr) 1999-04-01
CO4940489A1 (es) 2000-07-24
OA11312A (en) 2003-10-24
BR9810292A (pt) 2000-09-19
NO20000230L (no) 2000-01-17
EP1001784A1 (en) 2000-05-24
ZA986364B (en) 2000-01-17
TR200000133T2 (tr) 2000-09-21

Similar Documents

Publication Publication Date Title
AR012998A1 (es) Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprende dichosensibilizador y dicho agente.
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
MY125516A (en) Novel composition based on thiazolidinedione and metformin and use
WO2001000223A3 (en) Multiple agent diabetes therapy
AR046210A1 (es) Preparacion solida
UY25798A1 (es) Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina tiazolidinadiónico.
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
CO4940454A1 (es) Nuevo metodo de tratamiento
AR016350A1 (es) Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos
UY25103A1 (es) Composición para el tratamiento de diabetes mellitus
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
AR013352A1 (es) Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
AR012638A1 (es) Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional
ECSP982593A (es) Nuevo metodo de tratamiento vi
ECSP993215A (es) Nueva composicion y uso
ECSP982541A (es) Nuevo metodo de tratamiento ii
ECSP982591A (es) Nuevo metodo de tratamiento iv
ECSP982535A (es) Nuevo metodo de tratamiento (i)
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
ECSP982542A (es) Nuevo metodo de tratamiento iii
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
ECSP982592A (es) Nuevo metodo de tratamiento v
AR010343A1 (es) Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica.